Clinical Trials Browser

Phase 2 × Thyroid Neoplasms × irofulven × Clear all

NCT00124527 2021-06-16

Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer

Phase 2 Completed

Thyroid Neoplasms